Voltage-gated sodium channels were differentially expressed in human normal prostate, benign prostatic hyperplasia and prostate cancer cells

Oncology Letters

Volumn 8, Issue 1, 2014, Pages 345-350

  Shan, Bin ^a   Dong, Mei ^b   Tang, He ^a   Wang, Na ^a   Zhang, Jin ^c   Yan, Changqing ^a   Jiao, Xiaocui ^a   Zhang, Hailin ^a   Wang, Chuan ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b HEBEI UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c FIRST HOSPITAL OF SHIJIAZHUANG   (China)

Author keywords

Benign prostatic hyperplasia; Cancer; mRNA; Prostate; Voltage gated sodium channel

Indexed keywords

MESSENGER RNA; SODIUM CHANNEL NAV1.2; SODIUM CHANNEL NAV1.5; SODIUM CHANNEL NAV1.6; SODIUM CHANNEL NAV1.7; VOLTAGE GATED SODIUM CHANNEL;

ADULT; ARTICLE; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROPHYSIOLOGICAL PROCEDURES; HUMAN; HUMAN CELL; HUMAN TISSUE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION; RNA EXTRACTION; SODIUM CURRENT; WHOLE CELL PATCH CLAMP;

EID: 84901228346     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2014.2110     Document Type: Article

References (32)

1. Catterall WA: The molecular basis of neuronal excitability. Science 223: 653-661, 1984.
2. Catterall WA: From ionic currents to molecular mechanisms: the structure and function of voltage-gated sodium channels. Neuron 26: 13-25, 2000.
3. Antzelevitch C, Brugada P, Borggrefe M, et al: Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. Circulation 111: 659-670, 2005.
4. Veltmann C, Schimpf R, Echternach C, et al: A prospective study on spontaneous fluctuations between diagnostic and non-diagnostic ECGs in Brugada syndrome: implications for correct phenotyping and risk stratification. Eur Heart J 27: 2544-2552, 2006.
5. Bennett PB, Yazawa K, Makita N and George AL Jr.: Molecular mechanism for an inherited cardiac arrhythmia. Nature 376: 683-685, 1995.
6. Waxman SG: Painful Na-channelopathies: an expanding universe. Trends Mol Med 19: 406-409
7. Oliva M, Berkovic SF and Petrou S: Sodium channels and the neurobiology of epilepsy. Epilepsia 53: 1849-1859, 2012.
8. Brackenbury WJ: Voltage-gated sodium channels and metastatic disease. Channels (Austin) 6: 352-361, 2012.
9. Baade PD, Youlden DR and Krnjacki LJ: International epidemiology of prostate cancer: geographical distribution and secular trends. Mol Nutr Food Res 53: 171-184, 2009.
10. Diss JK, Stewart D, Pani F, et al: A potential novel marker for human prostate cancer: voltage-gated sodium channel expression in vivo. Prostate Cancer Prostatic Dis 8: 266-273, 2005.
11. Diss JK, Fraser SP, Walker MM, Patel A, Latchman DS and Djamgoz MB: Beta-subunits of voltage-gated sodium channels in human prostate cancer: quantitative in vitro and in vivo analyses of mRNA expression. Prostate Cancer Prostatic Dis 11: 325-333, 2008.
12. + channels in human prostate cancer cell lines and their contribution to invasion in vitro. Am J Pathol 150: 1213-1221, 1997.
13. + currents in two prostatic tumour cell lines: contribution to invasiveness in vitro. FEBS Lett 369: 290-294, 1995.
14. Nguyen TP, Wang DW, Rhodes TH and George AL Jr: Divergent biophysical defects caused by mutant sodium channels in dilated cardiomyopathy with arrhythmia. Circ Res 102: 364-371, 2008.
15. Benson DW, Wang DW, Dyment M, et al: Congenital sick sinus syndrome caused by recessive mutations in the cardiac sodium channel gene (SCN5A). J Clin Invest 112: 1019-1028, 2003.
16. Sato PY, Musa H, Coombs W, et al: Loss of plakophilin-2 expression leads to decreased sodium current and slower conduction velocity in cultured cardiac myocytes. Circ Res 105: 523-526, 2009.
17. + channels and conduction velocity in murine hearts. Circ Res 109: 775-782, 2011.
18. Nomiya T, Tsuji H, Toyama S, et al: Management of high-risk prostate cancer: radiation therapy and hormonal therapy. Cancer Treat Rev 39: 872-878, 2013.
19. Diaz D, Delgadillo DM, Hernández-Gallegos E, et al: Functional expression of voltage-gated sodium channels in primary cultures of human cervical cancer. J Cell Physiol 210: 469-478, 2007.
20. Fraser SP, Diss JK, Chioni AM, et al: Voltage-gated sodium channel expression and potentiation of human breast cancer metastasis. Clin Cancer Res 11: 5381-5389, 2005.
21. Hernandez-Plata E, Ortiz CS, Marquina-Castillo B, et al: Overexpression of NaV 1.6 channels is associated with the invasion capacity of human cervical cancer. Int J Cancer 130: 2013-2023, 2012.
22. Roger S, Besson P and Le Guennec JY: Involvement of a novel fast inward sodium current in the invasion capacity of a breast cancer cell line. Biochim Biophys Acta 1616: 107-111, 2003.
23. Fraser SP, Grimes JA and Djamgoz MB: Effects of voltage-gated ion channel modulators on rat prostatic cancer cell proliferation: comparison of strongly and weakly metastatic cell lines. Prostate 44: 61-76, 2000.
24. Abdul M and Hoosein N: Voltage-gated sodium ion channels in prostate cancer: expression and activity. Anticancer Res 22: 1727-1730, 2002.
25. Smith P, Rhodes NP, Shortland AP, et al: Sodium channel protein expression enhances the invasiveness of rat and human prostate cancer cells. FEBS Lett 423: 19-24, 1998.
26. Brisson L, Gillet L, Calaghan S, et al: Na(V)1.5 enhances breast cancer cell invasiveness by increasing NHE1-dependent H(+) efflux in caveolae. Oncogene 30: 2070-2076, 2011.
27. Carrithers MD, Chatterjee G, Carrithers LM, et al: Regulation of podosome formation in macrophages by a splice variant of the sodium channel SCN8A. J Biol Chem 284: 8114-8126, 2009.
28. Diamandis EP and Yu H: Nonprostatic sources of prostate-specific antigen. Urol Clin North Am 24: 275-282, 1997.
29. Foster CS, Cornford P, Forsyth L, Djamgoz MB and Ke Y: The cellular and molecular basis of prostate cancer. BJU Int 83: 171-194, 1999.
30. de Kok JB, Verhaegh GW, Roelofs RW, et al: DD3 (PCA3), a very sensitive and specific marker to detect prostate tumors. Cancer Res 62: 2695-2698, 2002.
31. Chakravarti A and Zhai GG: Molecular and genetic prognostic factors of prostate cancer. World J Urol 21: 265-274, 2003.
32. Biki B, Mascha E, Moriarty DC, Fitzpatrick JM, Sessler DI and Buggy DJ: Anesthetic technique for radical prostatectomy surgery affects cancer recurrence: a retrospective analysis. Anesthesiology 109: 180-187, 2008.